Lawrence P. Wennogle
Corporate Officer/Principal bei ITI, Inc. (New York)
Profil
Lawrence P.
Wennogle is currently the Vice President-Drug Discovery at ITI, Inc. He previously worked as a Staff Scientist at Ciba-Geigy Corp.
and Novartis Pharmaceuticals Corp.
From 2003 to 2013, he was the Vice President-Drug Discovery at Intra-Cellular Therapies, Inc. He returned to the same position in 2013 and held it until 2019.
Dr. Wennogle received his undergraduate degree from Ithaca College and his doctorate from The University of Colorado in 1977.
Aktive Positionen von Lawrence P. Wennogle
| Unternehmen | Position | Beginn |
|---|---|---|
| ITI, Inc. (New York) | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Lawrence P. Wennogle
| Unternehmen | Position | Ende |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 01.07.2019 |
Intra-Cellular Therapies, Inc. /Old/
 Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Corporate Officer/Principal | 26.09.2013 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| Ciba-Geigy Corp. | Corporate Officer/Principal | - |
Ausbildung von Lawrence P. Wennogle
| The University of Colorado | Doctorate Degree |
| Ithaca College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
| Ciba-Geigy Corp. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| ITI, Inc. (New York) |
